CIK 0001655759
- Accelerated filer
ARVINAS, INC.
Sign in to watch- Ticker
- ARVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472566120
- Phone
- +1 203-535-1456
- Business address
- 395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,475
- in 1 filing, $1K under 10b5-1 plans
Net −$1,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-15 | Taylor Ian Chief Scientific Officer | Sale | −4,126 | $73.68 | $304K | 82,886 |
| 2022-02-15 | Taylor Ian Chief Scientific Officer | Sale | −3,841 | $74.64 | $287K | 79,045 |
| 2022-02-15 | Taylor Ian Chief Scientific Officer | Sale | −300 | $75.80 | $23K | 78,745 |
| 2022-02-15 | Taylor Ian Chief Scientific Officer | Sale | −100 | $76.58 | $8K | 78,645 |
| 2022-02-15 | Taylor Ian Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −20,000 | $19.36 | $387K | 37,633 |
| 2022-01-14 | Morrison Briggs Director | Exercise or conversion | +16,188 | $16.00 | $259K | 45,708 |
| 2022-01-14 | Morrison Briggs Director | Sale | −9,919 | $64.33 | $638K | 35,789 |
| 2022-01-14 | Morrison Briggs Director | Sale | −3,833 | $65.24 | $250K | 31,956 |
| 2022-01-14 | Morrison Briggs Director | Sale | −5,100 | $67.28 | $343K | 26,856 |
| 2022-01-14 | Morrison Briggs Director | Sale | −2,108 | $67.69 | $143K | 24,748 |
| 2022-01-14 | Morrison Briggs Director | Exercise or conversion · Stock Option (right to buy) | −16,188 | 16,682 | ||
| 2021-12-30 | Peck Ronald Chief Medical Officer | Exercise or conversion | +14,375 | $47.38 | $681K | 19,777 |
| 2021-12-30 | Peck Ronald Chief Medical Officer | Exercise or conversion | +5,625 | $26.58 | $150K | 25,402 |
| 2021-12-30 | Peck Ronald Chief Medical Officer | Sale | −11,371 | $80.35 | $914K | 14,031 |
| 2021-12-30 | Peck Ronald Chief Medical Officer | Sale | −8,629 | $80.96 | $699K | 5,402 |
| 2021-12-30 | Peck Ronald Chief Medical Officer | Exercise or conversion · Stock Option (right to buy) | −14,375 | 40,625 | ||
| 2021-12-30 | Peck Ronald Chief Medical Officer | Exercise or conversion · Stock Option (right to buy) | −5,625 | 46,559 | ||
| 2021-12-17 | Cassidy Sean A Chief Financial Officer | Exercise or conversion | +15,000 | $16.00 | $240K | 173,249 |
| 2021-12-17 | Cassidy Sean A Chief Financial Officer | Sale | −15,000 | $70.00 | $1.1M | 158,249 |
| 2021-12-17 | Cassidy Sean A Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −15,000 | 14,384 |
Page 12 of 32 · 628 trades